RBCs Diseases Flashcards
Aplastic Anemia
Bone marrow failure causing pancytopenia w/ hypocellular bone marrow
Mechanism: Bone Marrow Failure
Characteristic: Pancytopenia - Dec. RBCs, WBCs, Platelets
Classification
- Acquired - Idiopathic (no known cause), Secondary (chemicals, drugs)
- Inherited - Fanconi Anemia, Dyskeratosis Congenita, Shwachman Bodian Diamond Syndrom (SBDB)
Aplastic - Shwachman - Bodian Diamon Syndrome (SBDS)
* Mutation:
* Mechanism:
* Characteristic:
* Findings:
Mutation: Biallelic Mutation in SBDS gene
Mechanism: Mitotic Spindle Destabilization - short telomers in GRANULOCYTES
Characteristic: Pancreatic Insufficiency - GI Malabsorption
Findings:
Neutropenia
Hypocellular
Increase Fat Excretion, HbF
Paroxysmal Cold Hemoglobinuria (PCH)
Other name: Donath-Landsteiner Hemolytic Anemia
Common: Children
Cause: Anti-P autoantibody (IgG autohemolysin)
Mechanism: IgG Hemolysion targeting P antigen in RBCs at 4C (cold) or 37C (warm)
Diagnosis:
+ Anti-P Test (hemolysis)
+ DAT - Complement (C3b) only
+ Coombs Test
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Mutation: Phospatidylinositol Glycan Class A gene
Characteristics: Hemolysis during SLEEP
Mechanism: Deficiency in Glycosylphosophatidyl Inositol (GPI) that inactivates complement activity - CD 55, CD 59 - COMPLEMENT MEDIATED HEMOLYSIS
Hb C Disease
Mechanism: GA to Lysine in 6th position
PBF: SHORT THICK RBCs
Characteristic: Hexagonal/ Pyramid shaped pointed end Crystals
Diagnosis: HPLC/Hb Electrophoresis
HbS Diseases - Sicke Cell Anemia
Mutation: Beta Chain in GA to Valince in 6th position
Mechanism: Deoxygenatiom triggers Sickling of RBCs that results to low O2 Saturation and affecting HbS polymerization which then transforms to liquid crystalline (tactoids).
Characteristic: Normochromic Normocytic
Hallmark: Vasso-occlusions
G6PD Deficiency
Mutation: G6PD gene at Long arm X chromosome at Xq28 locus (most common enzymopathy)
Mechanism: Def G6PD results Dec. NADPH making susceptible to Oxidative stress (cannot detoxify H2O2) –> OXIDATIVE DAMAGE
Characteristic: Heinz Bodies (insoluble complex)
Gold Standard: Qualitative Spectrophotometric Assay - Fluorescence: Inc. NADPH
Other Test:
Fluorescence Spot Test
Methemoglobin Reductase Test (Dye Reduction - Brown: G6PD Deficient)
Pyruvate Kinase Deficiency (PKD)
Mutation: PKLR gene
Mechanism: Cannot generate ATP -> Dehydration -> SHRINKAGE
Characteristics:
(+) Howell Jolly Bodies, Papenheimer Bodies
(+) Echinocyte, Target Cells, Burr Cells
Diagnosis: NAD+ is proportional to PK activity (No fluorescence)
1. Quantitative PK Assays:
2. Qualitative PK Assays
Overhydrated Hereditart Stomatocytosis (OHS)
Mutation: RHAG gene
Deficiency: Stomatin (regulation of ion channels)
Mechanism: Cation Permeability with Increase - Na+, Decrease - K –> Swelling
Findings: Decrease - OFT, Increase - EMA
Dehydrated Hereditary Stomatocytosis/Hereditary Xeroxytosis
Mutation: PEIZO1 gene
Mechanism: Net DECREASED cation - Increased K+, Decreased: Na+ –> Shrinkage
Findongs: Decreased - OFT, EMA
Three major mechanism of Anemia
Blood Loss
Impaired red cell production
Accelerated red cell destruction
Three major laboratory findings of Anemia
Decreased RBC, Hb, and Hct
Hemoglobin is a more reliable indicator of anemia
Absolute reticulocyte count
Determine the mechanism of Anemia
Absolute Reticulocyte Count
* High
* Low
Absolute Reticulocyte Count
* High - Excessive RBC loss
* Low - decreased RBC production
Anisochromia
Variation in Hemoglobin concentration
Poikilocytosis
variation in shape
Anisocytosis
variation in size
Microcytic Hypochromic Anemia
IDA
most common anemia
Loss or insufficient Fe that results to ineffective Hb production
Cuases - IDA
Chronic Blood Loss
Increased Iron utilization
* Pregnancy
* Adolescent growth
Impaired Iron absorption
* Celiac
* Achlorhydria
Parasitic Infection
* Hookworm: N. americanus, A. duodenale
* T. trichiura
* Schistosoma: S. mansonii, S. haematobium
Pathophysiology - IDA
* Stage 1/Pre-latent
* Stage 2/Latent
* Stage 3/Anemia
Pathophysiology - IDA
* Stage 1: Storage - Iron depletion (Prelatent)
* Stage 2: Transferrin - Iron deficient eryhthropoiesis (Latent)
* Stage 3: Functional - Anemia
Laboratory Findings - IDA
* RBCs
* Poikilocytes
* Decreased
* Increased
Laboratory Findings - IDA
- RBCs: Microcytic Hypochromic cells
- Poikilocytes: Target cells, Elliptocytes, Ovalocyte, Dacrocyte
- Decreased: Reticulocyte count, Serum Iron, Serum Ferritin
- Increased: RDW, TIBC
70%
Functional iron in Hb
PERCENTAGE OF HYPOCHROMIC RED BLOOD CELLS (% HYPO)
MOST
SENSITIVE and SPECIFIC parameter of Functional Iron Deficiency.
Soluble transferrin receptor (sTfR):
provide **differentiation of IDA from anemia of
chronic inflammation disorders
Increased in IDA, Decreased in ACD
Anemia of Inflammation
Anemia of Chronic Disease
Inability to use iron due to low iron absorption with Increased hepcidin
Hepcidin
key molecule that regulate (inhibiting) iron absorption by inactivating ferroportin
causing to impaired release of iron in blood circulation
Causes - ACD
Infection (TB, Fungal)
Malignancy (MM, Cancer)
Autoimmune (SLE, RA, Sarcoidosis)
Laboratory Findings - ACD
* RBCs:
* Increased:
* Decreased:
Laboratory Findings - ACD
* RBCs: normocytic normochromic
* Increased: Storage Iron, Ferritin, ESR
* Decreased: TIBC, Serumn Iron, sTfr
Serum iron is low because recycling of iron from macrophages is impaired
Mechanism - Sideroblastic Anemia
Ineffective erythropoiesis due to enzyme deficiency - 5 aminolevulinic acid synthase & uroporphyrinogen decarboxylase, that result to Iron overload
5 amino livulenic acid synthetase & auropophyrinogen decarboxylase
Enzyme defciency in Sideroblastic anemia
Lab Findings - Sideroblastic Anemia
* Increased:
* Decreased:
Lab Findings - Sideroblastic Anemia
* Increased: Serum Iron, Ferritin
* Decreased:** TIBC**
Differentiated to ACD - Serum Iron
Beta-thalassemia Trait
a.k.a. Minor beta-thalassemia
One beta gene deletion with mild anemia
CARRIER STATE
HbA2
Increased hemoglobin in beta-thalassemia minor
Beta-thalassemia Minor
* Deletion:
* Anemia:
* Increased hemoglobin
Minor beta-thalassemia
* Deletion: 1 beta chain deletion
* Anemia: Mild/Silent
* Increased hemoglobin: HbA2
Mild Cooley’s Anemia
Beta-thalassemia intermedia
Beta-thalassemia Intermedia
* Deletion:
* Anemia:
* Lab Findings:
Beta-thalassemia Intermedia
* Deletion: Bothe genes are variant
* Anemia: Moderate anemia
* Lab Findings: Microcytosis, Splenomegaly, Low indices, High RDW
Beta thalassemia Major
a.k.a Cooley’s Anemia/Mediterranian Anemia
Absence of beta chains with severe anemia
No HbA is produced
HbF (90%)
Increased Hb (compensatory) in beta-thalassemia major
Laboratory Findings - Beta thalassemia Major
* RBC:
* Anemia:
* Poikilocytes:
* BM:
* Hb:
* Increased:
Laboratory Findings - Beta thalassemia Major
* RBC: Microcytic hypochromic
* Anemia: Severe Anemia
* Poikilocytes: Target cells, teardrop cells
* Inclusions: Basophilic stippling, Howell-Jolly bodies, Papenheimer bodies
* BM: Hypercellular
* Hb: 2-3 mg/dL
* Increased: Serum Iron, Bilirubin
Beta thalassemia major is **transfusion dependent **
4 Classification of a-thalassemia
- Silent carrier - 1 alpha gene deletion
- a-thalassemia minor - 2 alpha gene deletion
- Hb H disease - 3 alpha gene deletion
- a-thalassemia major - 4 alpha gene deletion
Silent carrier
a.k.a heterozygous alpha thalassemia
1 alpha gene deletion without signs and symptoms of anemia
Alpha thalassemia Minor
a.k.a alpha thalassemia trait
2 alpha gene deletion with Mild anemia
Thalassemia common in Souteast Asian
alpha thalassemia minor
Laboratory findings - Alpha thalassemia Minor/Trait
* RBCs:
* Anemia:
* Hb:
* Low:
* Poikilocytes:
Laboratory findings - Alpha thalassemia Minor/Trait
* RBCs: Mild microcytic, hypocheomic
* Anemia: Mild anemia
* Hb: 12-13 g/dL
* Low: MCV, MCH, MCHC
* Poikilocytes: Target cells